Matrixome Company
Matricome aims to contribute to the realization and development of regenerative medicine by disseminating laminin E8 fragment technology.
Technology:
Regenerative Medicine
Industry:
Medical, Nursing and Residential Care, Product Research
Headquarters:
Japan
Founded Date:
2015-12-03
Employees Number:
11-50
Investors Number:
2
Total Funding:
275000000
Last Funding Date:
42398
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership